Marex Group PLC (MRX) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows strong growth potential supported by bullish analyst ratings, positive financial performance, and a favorable technical setup. Despite the lack of recent proprietary trading signals, the overall data suggests a solid entry point for long-term gains.
The technical indicators for MRX are bullish. The MACD histogram is positive at 0.942, indicating upward momentum. The RSI_6 at 73.354 is in the neutral zone but trending higher. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading near its resistance level of 44.148, suggesting potential for further upside.

Analysts have consistently raised price targets, with UBS, TD Cowen, and Barclays highlighting strong growth potential and AI-related opportunities.
Financial performance in Q4 2025 was exceptional, with revenue up 126.86% YoY and EPS up 55.41% YoY.
The stock has a 19.93% chance of gaining in the next month based on historical patterns.
Gross margin dropped to 0, which could indicate cost management issues.
No significant hedge fund or insider trading activity, which might suggest limited institutional confidence in the short term.
In Q4 2025, Marex Group PLC demonstrated strong financial growth. Revenue increased by 126.86% YoY to $800.8M, net income rose by 43.92% YoY to $81.6M, and EPS grew by 55.41% YoY to 1.15. However, gross margin dropped to 0, which is a concern.
Analysts are bullish on MRX. UBS raised its price target to $60, citing increased revenue growth outlook and new growth avenues. TD Cowen increased its target to $66, highlighting a potential P/E multiple expansion. Barclays raised its target to $55, emphasizing AI-related opportunities and strong preliminary Q1 estimates.